Determinants of obesity-associated insulin resistance

Information

  • Research Project
  • 10386286
  • ApplicationId
    10386286
  • Core Project Number
    K23HL135394
  • Full Project Number
    3K23HL135394-05S1
  • Serial Number
    135394
  • FOA Number
    PA-20-272
  • Sub Project Id
  • Project Start Date
    2/1/2017 - 7 years ago
  • Project End Date
    1/9/2022 - 2 years ago
  • Program Officer Name
    SCOTT, JANE
  • Budget Start Date
    9/10/2021 - 2 years ago
  • Budget End Date
    1/9/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    05
  • Suffix
    S1
  • Award Notice Date
    9/9/2021 - 2 years ago
Organizations

Determinants of obesity-associated insulin resistance

This extension request describes a 4-month funded extension for the K23 awardee who is in her final year of funding (5K23HL135394-05). The recipient experienced an 8-month research interruption due to lab closures and clinical research restrictions on Boston University Medical Campus due to the COVID- 19 pandemic. Further COVID-19 disruptions extended this research interruption by an additional 19- weeks. However, with the current COVID-19 situation improving in the Boston area, the applicant?s research program is operating at maximum capacity and will generate sound scientific data for the outcomes in Aims 1 and 2 within the original funding period. The 4-month funded extension is essential for this early stage investigator to develop more complete and scientifically robust answers to the outcomes proposed in Aim 3 that are currently trending toward significance. Briefly, Aim 3 examines the effect of surgical weight loss on insulin resistance, micro- and macrovascular functions, fat tissue histopathology and adipose tissue characteristics by CT imaging. During the 8-month COVID-19 shut down, 35% of the enrolled participants became ineligible for their 6-month post bariatric surgical return visit. Thus, the combination of her current recruiting efforts and the additional 4-months extension of salary support will not only provide time but the resources to complete the studies that are likely to provide novel and clinically important information regarding mechanisms of obesity-related vascular disease in severely obese individuals.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    K23
  • Administering IC
    HL
  • Application Type
    3
  • Direct Cost Amount
    39468
  • Indirect Cost Amount
    3157
  • Total Cost
    42625
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    837
  • Ed Inst. Type
    SCHOOLS OF MEDICINE
  • Funding ICs
    NHLBI:42625\
  • Funding Mechanism
    OTHER RESEARCH-RELATED
  • Study Section
  • Study Section Name
  • Organization Name
    BOSTON UNIVERSITY MEDICAL CAMPUS
  • Organization Department
    INTERNAL MEDICINE/MEDICINE
  • Organization DUNS
    604483045
  • Organization City
    BOSTON
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    021182841
  • Organization District
    UNITED STATES